Por: CNBC Health November 30, 2022
Alzheimer's is the most common form of dementia, a general term for loss of memory, language, and other thinking abilitiesBrian B. Bettencourt Toronto Star Getty ImagesA trial of an experimental Alzheimer's drug has been hailed as a new era in the beleaguered fight to find a cure for dementia.Results from the clinical trial showed that the medicine lecanemab removed clumps of protein — called beta amyloid — that builds up in brains... + full article
ABC7 USA Health December 01, 2022
treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association with certain serious adverse events.Lecanemab has become one of the first experimental dementia drugs to appear to slow the progression of cognitive... + más
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes
Alzheimer's drug trial shown to slow cognitive decline in long fight against dementia | CNBC
The Advocate USA Health November 16, 2022
What is vascular dementia?Similar to Alzheimer’s disease, vascular dementia is a type of dementia caused by reduced blood flow to the brain, which damages and eventually kills brain cells. It is generally considered the second most common subtype of dementia, which is an... + más
Stroke can lead to vascular dementia: Alzheimer's Q&A | The Advocate
How To Spot The Early Signs Of Alzheimer's | Newsweek
What is the Lumipulse test for Alzheimer’s disease?In May, the U.S. Food and Drug Administration permitted marketing of the Lumipulse (G B-Amyloid Ratio [1-42/1-40]) test to Fujirebio Diagnostics, Inc. of Malvern, Pennsylvania. The test, which was granted Breakthrough Device... + más
Why Isn’t There an Effective Alzheimer’s Treatment Yet? | Slate
Forbes USA Tech October 22, 2022
A person walks on a suspended rope bridge in the clouds. Extreme attraction.getty This article is the fourth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in , , and of the series. The pharmaceutical and biotech companies, Eisai and... + más
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
Variety of factors play a role in the development of Alzheimer's | The Advocate
Newsweek USA Health September 24, 2022
The Alzheimer's Association defines Alzheimer's as a brain disease that causes a slow decline in memory, thinking and reasoning skills. Dementia refers to the symptoms of Alzheimer's that can worsen over time.They predict that by 2050, the number of people aged 65... + más
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
The Advocate USA Health September 17, 2022
'Words just wouldn’t come': Oklahoma news anchor describes on-air medical emergency | 10 WBNS
Alzheimer's Q&A: Sildenafil has potential as Alzheimer's drug | The Advocate
About iurex | Privacy Policy | Disclaimer |